N-(4-(4-Fluorophenyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)methanesulfonamide

Catalog No. :
ACVKBC541
CAS No. :
945966-46-1
Molecular Formula :
C17H17FN2O4S
Molecular Weight :
364.40

IUPAC Name:N-(4-(4-fluorophenyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)methanesulfonamide

N-(4-(4-Fluorophenyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)methanesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg97%$64.00Login to see priceInquiryInquiry
10mg97%$91.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-(4-Fluorophenyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)methanesulfonamide
IUPAC NameN-(4-(4-fluorophenyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)methanesulfonamide
MDL No.MFCD31657369
Molecular FormulaC17H17FN2O4S
Molecular Weight364.40
SMILESCS(=O)(NC1=CC=C2N(C3=CC=C(F)C=C3)C(C(C)(C)OC2=C1)=O)=O
InChI KeyAZNHWXAFPBYFGH-UHFFFAOYSA-N
SynonymMT-3995
CAS No.945966-46-1
PubChem CID24744336

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACVKBC541 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVKBC541 route product structure diagram
    ACVKBC541945966-46-1
Inquiry

2. ACVKBC541 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIEQC162 route compound structure diagram
    ACIEQC162448-59-9 In Stock
  4. Then
  5. ACVKBC541 route product structure diagram
    ACVKBC541945966-46-1
Inquiry

Comments (0)